Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P V Plourde

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Breast Cancer Research and Treatment|January 1, 1994
Arimidex: a potent and selective fourth-generation aromatase inhibitorP V Plourde, M Dyroff, M Dukes
American Journal of Diseases of Children (1960)|November 1, 1983
Clomiphene in the treatment of adolescent gynecomastia. Clinical and endocrine studiesP V Plourde, H E Kulin, S J Santner
Journal of the American Academy of Dermatology|May 1, 1984
Acanthosis nigricans and insulin resistanceP V Plourde, J G Marks, J M Hammond
Seminars in Oncology|August 1, 1996
Aromatase inhibitors in metastatic breast cancerA U Buzdar, P V Plourde, G N Hortobagyi
The Journal of Clinical Endocrinology and Metabolism|April 1, 1985
Impotence associated with low biological to immunological ratio of luteinizing hormone in a man with a pituitary stoneP V Plourde, M Dufau, N Plourde, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 1, 1997
ARIMIDEX: a potent and selective aromatase inhibitor for the treatment of advanced breast cancerA U Buzdar, W Jonat, A Howell, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1995
ARIMIDEX: a new oral, once-a-day aromatase inhibitorP V Plourde, M Dyroff, M Dowsett, et al.
Archives of Internal Medicine|June 1, 1986
Thallium-technetium parathyroid scan. A useful noninvasive technique for localization of abnormal parathyroid tissueA Manni, R M Basarab, P V Plourde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study GroupA Buzdar, W Jonat, A Howell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2- breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2S Damodaran, C C O'Sullivan, A Elkhanany, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Breast Cancer Research and Treatment|January 1, 1994
Arimidex: a potent and selective fourth-generation aromatase inhibitorP V Plourde, M Dyroff, M Dukes
American Journal of Diseases of Children (1960)|November 1, 1983
Clomiphene in the treatment of adolescent gynecomastia. Clinical and endocrine studiesP V Plourde, H E Kulin, S J Santner
Journal of the American Academy of Dermatology|May 1, 1984
Acanthosis nigricans and insulin resistanceP V Plourde, J G Marks, J M Hammond
Seminars in Oncology|August 1, 1996
Aromatase inhibitors in metastatic breast cancerA U Buzdar, P V Plourde, G N Hortobagyi
The Journal of Clinical Endocrinology and Metabolism|April 1, 1985
Impotence associated with low biological to immunological ratio of luteinizing hormone in a man with a pituitary stoneP V Plourde, M Dufau, N Plourde, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 1, 1997
ARIMIDEX: a potent and selective aromatase inhibitor for the treatment of advanced breast cancerA U Buzdar, W Jonat, A Howell, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1995
ARIMIDEX: a new oral, once-a-day aromatase inhibitorP V Plourde, M Dyroff, M Dowsett, et al.
Archives of Internal Medicine|June 1, 1986
Thallium-technetium parathyroid scan. A useful noninvasive technique for localization of abnormal parathyroid tissueA Manni, R M Basarab, P V Plourde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study GroupA Buzdar, W Jonat, A Howell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2- breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2S Damodaran, C C O'Sullivan, A Elkhanany, et al.
Pageof 2